(VIANEWS) – Nikkei 225 (N225) is currently on bearish momentum. At 00:08 EST on Friday, 1 July, Nikkei 225 (N225) is at 25,911.23, 1.83% down since the last session’s close.
Nikkei 225 Range
About Nikkei 225’s daily highs and lows, it’s 1.57% down from its trailing 24 hours low of $26,324.30 and 3.15% down from its trailing 24 hours high of $26,753.30.
Concerning Nikkei 225’s yearly highs and lows, it’s 4.98% up from its 52-week low and 15.86% down from its 52-week high.
Volatility
Nikkei 225’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.39%, a negative 0.12%, and a positive 1.03%, respectively.
Nikkei 225’s highest amplitude of average volatility was 1.00% (last week), 0.99% (last month), and 1.03% (last quarter), respectively.
Index Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nikkei 225’s is considered to be overbought (>=80).
News about S&P 500
- According to FXStreet on Tuesday, 28 June, "While portraying the mood, the S&P 500 Futures retreat from a two-week high flashed the previous day, down 0.15% intraday around 3,897 at the latest. "
- According to FXStreet on Tuesday, 28 June, "While portraying the mood, the S&P 500 Futures retreat from a two-week high flashed the previous day, down 0.15% intraday around 3,897 at the latest. "
- According to FXStreet on Tuesday, 28 June, "The risk appetite, however, remains cautiously optimistic as the S&P 500 Futures print mild gains while the US 10-year Treasury yields probe a two-day rebound around 3.19% by the press time."
- According to FXStreet on Tuesday, 28 June, "In a soft-landing scenario, in which earnings growth expectations for 2023 are close to flat year-on-year, we would expect the S&P 500 to end the year close to current levels at 3,900.", "If worsening economic data leads earnings forecasts to be revised down to around -15%, in line with average declines during recessions, we would expect the S&P 500 to trade around 3,300."
- According to MarketWatch on Tuesday, 28 June, "Roivant’s stock has tumbled 53.6% year to date through Monday, while Pfizer shares have lost 12.1% and the S&P 500 has declined 18.2%."
More news about Nikkei 225 (N225).